English | 简体中文 | 繁體中文 | 한국어 Home | About us | Services | Partners | Events | Contact us | Login Friday, March 06, 2026  Trad. Chinese Press Releases Language: All English Indonesian Japanese Korean Thai Trad. Chinese Simp. Chinese Vietnamese  Medicine Clinical Trials Agilex Biolabs與Endpoints新聞合作開展消卷積炎症和免疫學臨床試驗 May 21, 2021 13:00 HKT Agilex Biolabs祝賀Bionomics Limited BNC210 PK上的結果 Apr 30, 2021 14:00 HKT Agilex Biolabs收購領先的Biolab TetraQ作為APAC擴展計劃的一部分 Apr 07, 2021 15:00 HKT AIM ImmunoTech宣布其藥物Ampligen的ME/CFS臨床試驗已開始接受COVID-19長期患者的註冊 Dec 24, 2020 21:00 HKT << Previous  Next >>  Releases By Industry Business ASEAN Daily News Government HR Local Biz SMEs Startups Trade Show Communications Advertising Broadcast, Film & Sat Media & Marketing Telecoms Wireless & Mobility CryptoCurrency Blockchain Technology Crypto, Exchange ICO Metaverse, Games Mining & Staking NFTs Financial Banking & Insurance Cards & Payments Daily Finance Exchanges & Software FinTech Funds & Equities Legal & Compliance Venture Capital & PE Real Estate & REIT Trade Finance Industrial Aerospace & Defence Airlines Automotive Chemical General Construct, Engineering Cosmetics, Spec.Chem Food & Beverages Manufacturing Marine & Offshore Metals & Mining Oil & Gas Print & Package Transport & Logistics Lifestyle Design & Art Beauty & Skin Care Boating Education Gaming Fashion & Apparel Hospitality Motorsports Regional, Lifestyle Retail & eCommerce Sports Travel & Tourism Watches & Jewelry Medicine Alternative BioTech Clinical Trials Healthcare & Pharm MedTech Sustainablity Agritech Alternative Energy Energy Environment, ESG EVs, Transportation Smart Cities Water Technology Artificial Intel [AI] Automation [IoT] CyberSecurity Datacenter & Cloud Digital World Electronics Engineering Enterprise IT Materials & Nanotech Copyright © 2026 ACN Newswire - Asia Corporate News Network Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575 Connect With us: